BIO
Bio Rad Laboratories Inc
Price:  
338.64 
USD
Volume:  
569,372.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BIO EV/EBITDA

-9.7%
Upside

As of 2024-02-22, the EV/EBITDA ratio of Bio Rad Laboratories Inc (BIO) is 26.60. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BIO's latest enterprise value is 10,612.36 mil USD. BIO's TTM EBITDA according to its financial statements is 398.90 mil USD. Dividing these 2 quantities gives us the above BIO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 18.9x - 20.7x 20.5x
Forward P/E multiples 18.6x - 19.7x 19.0x
Fair Price 233.49 - 369.18 305.78
Upside -31.1% - 9.0% -9.7%
338.64 USD
Stock Price
305.78 USD
Fair Price

BIO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-21 -64.31
2024-02-20 -65.28
2024-02-16 -64.67
2024-02-15 -62.43
2024-02-14 -62.27
2024-02-13 -60.03
2024-02-12 -61.97
2024-02-09 -61.76
2024-02-08 -61.93
2024-02-07 -61.75
2024-02-06 -61.72
2024-02-05 -60.53
2024-02-02 -60.85
2024-02-01 -62.47
2024-01-31 -60.94
2024-01-30 -63.13
2024-01-29 -62.68
2024-01-26 -62.49
2024-01-25 -60.07
2024-01-24 -60.12
2024-01-23 -59.87
2024-01-22 -59.41
2024-01-19 -58.23
2024-01-18 -57.75
2024-01-17 -57.75
2024-01-16 -59.86
2024-01-12 -60.50
2024-01-11 -60.93
2024-01-10 -60.91
2024-01-09 -60.35
2024-01-08 -61.14
2024-01-05 -60.08
2024-01-04 -60.10
2024-01-03 -60.55
2024-01-02 -62.29
2023-12-29 -61.32
2023-12-28 -61.65
2023-12-27 -61.18
2023-12-26 -60.95
2023-12-22 -60.91
2023-12-21 -60.69
2023-12-20 -58.55
2023-12-19 -59.85
2023-12-18 -58.48
2023-12-15 -58.13
2023-12-14 -59.25
2023-12-13 -59.68
2023-12-12 -55.98
2023-12-11 -57.74
2023-12-08 -57.75